These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17624026)

  • 1. In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS.
    Kammerer B; Scheible H; Zurek G; Godejohann M; Zeller KP; Gleiter CH; Albrecht W; Laufer S
    Xenobiotica; 2007 Mar; 37(3):280-97. PubMed ID: 17624026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor.
    Kammerer B; Scheible H; Albrecht W; Gleiter CH; Laufer S
    Drug Metab Dispos; 2007 Jun; 35(6):875-83. PubMed ID: 17344341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites.
    Chavan BB; Tiwari S; G S; Nimbalkar RD; Garg P; R S; Talluri MVNK
    J Pharm Biomed Anal; 2018 Aug; 157():59-74. PubMed ID: 29772457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of biotransformation products of the fungicide fluopyram by electrochemistry coupled online to liquid chromatography-mass spectrometry and comparison with in vitro microsomal assays.
    Mekonnen TF; Panne U; Koch M
    Anal Bioanal Chem; 2018 Apr; 410(10):2607-2617. PubMed ID: 29455286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From 2-Alkylsulfanylimidazoles to 2-Alkylimidazoles: An Approach towards Metabolically More Stable p38α MAP Kinase Inhibitors.
    Heider F; Haun U; Döring E; Kudolo M; Sessler C; Albrecht W; Laufer S; Koch P
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29036906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.
    Stearns RA; Miller RR; Arison BH; Rosegay A; Smith JL; Mantlo NB; Chiu SH
    Drug Metab Dispos; 1993; 21(4):670-6. PubMed ID: 8104127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series.
    Ceccarelli SM; Schlotterbeck G; Boissin P; Binder M; Buettelmann B; Hanlon S; Jaeschke G; Kolczewski S; Kupfer E; Peters JU; Porter RH; Prinssen EP; Rueher M; Ruf I; Spooren W; Stämpfli A; Vieira E
    ChemMedChem; 2008 Jan; 3(1):136-44. PubMed ID: 17994660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Solid Phase Extraction (SPE) LC/NMR Applied to the Structural Analysis of Extractable Compounds from a Pharmaceutical Packaging Material of Construction.
    Norwood DL; Mullis JO; Davis M; Pennino S; Egert T; Gonnella NC
    PDA J Pharm Sci Technol; 2013; 67(3):267-87. PubMed ID: 23752753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of in vitro phase I metabolites of methamnetamine in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Hong YK; Kim YH; Lee JM; Yoo HH; Choi SO; Kang MS
    Int J Legal Med; 2021 Jul; 135(4):1471-1476. PubMed ID: 33928430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of electrospray ionization hybrid ion trap/time-of-flight mass spectrometry in the rapid characterization of quinocetone metabolites formed in vitro.
    Liu ZY; Huang LL; Chen DM; Dai MH; Tao YF; Wang YL; Yuan ZH
    Anal Bioanal Chem; 2010 Feb; 396(3):1259-71. PubMed ID: 20020112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the in vitro metabolic profile of a new α
    de O Cardoso J; da Silva BF; Venâncio T; da Rocha Pitta MG; da R Pitta I; Peccinini RG; Oliveira RV
    J Pharm Biomed Anal; 2019 Aug; 172():67-77. PubMed ID: 31029802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite characterization of ambrisentan, in in vitro and in vivo matrices by UHPLC/QTOF/MS/MS: Detection of glutathione conjugate of epoxide metabolite evidenced by in vitro GSH trapping assay.
    Johnsi Rani P; Vishnuvardhan C; Nimbalkar RD; Garg P; Satheeshkumar N
    J Pharm Biomed Anal; 2018 Jun; 155():320-328. PubMed ID: 29684813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry.
    Kim E; Kim H; Suh K; Kwon S; Lee G; Park NH; Hong J
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1183-95. PubMed ID: 23650031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats.
    Koch DA; Silva RB; de Souza AH; Leite CE; Nicoletti NF; Campos MM; Laufer S; Morrone FB
    Rheumatology (Oxford); 2014 Mar; 53(3):425-32. PubMed ID: 24241037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new reactive metabolite of pyrrolizidine alkaloid retrorsine: (3H-pyrrolizin-7-yl)methanol.
    Fashe MM; Juvonen RO; Petsalo A; Rahnasto-Rilla M; Auriola S; Soininen P; Vepsäläinen J; Pasanen M
    Chem Res Toxicol; 2014 Nov; 27(11):1950-7. PubMed ID: 25295702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.